Picture of Interpace Biosciences logo

IDXG Interpace Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Interpace Biosciences Q2 Revenue USD 12.001 Million

Aug 01 (Reuters) - Interpace Biosciences Q2 operating income USD 2.216
million.
* Q2 net income USD 2.021 million
* Q2 operating expenses USD 5.174 million
* Q2 gross profit USD 7.39 million

Recent news on Interpace Biosciences

See all news